Get started
Author

Gaetano Corazzelli

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
2009 · Andrés JM Ferreri, Michele Reni, et al. · The Lancet · 662
Temozolomide as salvage treatment in primary brain lymphomas
2007 · M Reni, F Zaja, et al. · British Journal of Cancer · 163
PDF
Response and Toxicity to Cytarabine Therapy in Leukemia and Lymphoma: From Dose Puzzle to Pharmacogenomic Biomarkers
2021 · Raffaele Di Francia, Stefania Crisci, et al. · Cancers · 131
PDF
MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas
2006 · A.J.M. Ferreri, S. Dell’Oro, et al. · Neurology · 94
RD‐CODOX‐M/IVAC with rituximab and intrathecal liposomal cytarabine in adult Burkitt lymphoma and ‘unclassifiable’ highly aggressive B‐cell lymphoma
2011 · Gaetano Corazzelli, Ferdinando Frigeri, et al. · British Journal of Haematology · 82
Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma
2009 · Gaetano Corazzelli, Gaetana Capobianco, et al. · Cancer Chemotherapy and Pharmacology · 76
Efficacy and safety of bendamustine for the treatment of patients with recurring H odgkin lymphoma
2012 · Gaetano Corazzelli, Francesco Angrilli, et al. · British Journal of Haematology · 63
PDF
Biweekly rituximab, cyclophosphamide, vincristine, non‐pegylated liposome‐encapsulated doxorubicin and prednisone (R‐COMP‐14) in elderly patients with poor‐risk diffuse large B‐cell lymphoma and moderate to high ‘life threat’ impact cardiopathy
2011 · Gaetano Corazzelli, Ferdinando Frigeri, et al. · British Journal of Haematology · 58
PDF
MATILDE chemotherapy regimen for primary CNS lymphoma
2014 · Andrés J.M. Ferreri, Fabio Ciceri, et al. · Neurology · 44
Gemcitabine, ifosfamide, oxaliplatin and rituximab (R-GIFOX), a new effective cytoreductive/mobilizing salvage regimen for relapsed and refractory aggressive non-Hodgkin's lymphoma: results of a pilot study
2006 · G. Corazzelli, F. Russo, et al. · Annals of Oncology · 41
Dendritic cells in hematological malignancies
2016 · Domenico Galati, Gaetano Corazzelli, et al. · Critical Reviews in Oncology/Hematology · 36
Aging and the hemopoietic system
2003 · Antonio Pinto, Rosaria De Filippi, et al. · Critical Reviews in Oncology/Hematology · 34
Clinical Relevance of the Dose of Cytarabine in the Upfront Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Combination
2011 · Andrés J. M. Ferreri, Giada Licata, et al. · The Oncologist · 33
PDF
Tumor flare reactions and response to lenalidomide in patients with refractory classic Hodgkin lymphoma
2009 · Gaetano Corazzelli, Rosaria De Filippi, et al. · American Journal of Hematology · 32
PDF
Pentostatin (2'-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas.
2005 · Gaetano Corazzelli, Gaetana Capobianco, et al. · PubMed · 31
DMSO-associated encephalopathy during autologous peripheral stem cell infusion: a predisposing role of preconditioning exposure to CNS-penetrating agents?
2009 · G Marcacci, G Corazzelli, et al. · Bone Marrow Transplantation · 22
Circulating dendritic cells deficiencies as a new biomarker in classical Hodgkin lymphoma
2018 · Domenico Galati, Serena Zanotta, et al. · British Journal of Haematology · 19
Gemcitabine, Ifosfamide, Oxaliplatin (GIFOX) as First-Line Treatment In High-Risk Peripheral T-Cell/NK Lymphomas: A Phase II Trial.
2010 · Gaetano Corazzelli, Ferdinando Frigeri, et al. · Blood · 14
Elevation of clonal serum free light chains in patients with HIV‐negative primary effusion lymphoma (PEL) and PEL‐like lymphoma
2009 · Rosaria De Filippi, Giancarla Iaccarino, et al. · British Journal of Haematology · 14
Abnormally Elevated Levels of Serum Free-Immunoglobulin Light Chains Are Frequently Found in Classic Hodgkin Lymphoma (cHL) and Predict Outcome of Patients with Early Stage Disease.
2009 · Rosaria De Filippi, Filippo Russo, et al. · Blood · 12
Continuous Exposure to Bendamustine (BDM) Results in Stable Upregulation of CD30 and Increased Sensitivity to Brentuximab Vedotin (BV) in Tumor Cells of Hodgkin Lymphoma (HL)
2015 · Rosaria De Filippi, Michele Cillo, et al. · Blood · 11
A phase II study of dose‐dense and dose‐intense ABVD ( ABVD DD‐DI) without consolidation radiotherapy in patients with advanced H odgkin lymphoma
2014 · Filippo Russo, Gaetano Corazzelli, et al. · British Journal of Haematology · 11
Safety and Preliminary Efficacy of Sabestomig (AZD7789), an Anti-PD-1 and Anti-TIM-3 Bispecific Antibody, in Patients with Relapsed or Refractory Classical Hodgkin Lymphoma Previously Treated with Anti-PD-(L)1 Therapy
2023 · Matthew G. Mei, Gaetano Corazzelli, et al. · Blood · 9
Rituximab plus gemcitabine, ifosfamide, oxaliplatin (R-GIFOX) as salvage therapy for recurrent Hodgkin lymphoma
2009 · G. Corazzelli, F. Frigeri, et al. · Journal of Clinical Oncology · 8
Randomized Phase II Trial on Primary Chemotherapy with High-Dose Methotrexate Alone or Associated with High-Dose Cytarabine for Patients with Primary CNS Lymphoma (IELSG #20 Trial): Tolerability, Activity and Event-Free Survival Analysis
2008 · Andres JM Ferreri, Michele Reni, et al. · Blood · 7
Works count: 79
Citation count: 1,771
H-index: 17
I10-index: 22
Year
Topic
Type